Pradžia › Vėžys (visų tipų) › Vermont
Vėžys (visų tipų) klinikiniai tyrimai Vermont
7 tyrimai dėl Vėžys (visų tipų) ieško dalyvių vietose Vermont.
Miestai Vermont
Oficialus tyrimo tekstas (anglų kalba)
Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
- White River Junction Veterans Healthcare System, White River Junction
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-16 · NCT05796375A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- The University of Vermont Medical Center Inc., Burlington
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-08 · NCT06119581Project: Every Child for Younger Patients With Cancer
- University of Vermont and State Agricultural College, Burlington
Renkami dalyviaiStebimasis tyrimas
Iki 25 metų · Visoms lytims · Atnaujinta 2026-08-25 · NCT02402244Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes
- University of Vermont Cancer Center, Burlington
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-08-10 · NCT07061652Care Coordination Educational Intervention Study for Patients From Rural Areas With Early Stage Cancer
- University of Vermont Cancer Center, Burlington
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-04 · NCT05723250DOAC - Dosing Options in AntiCoagulation Prophylaxis
- University of Vermont Medical Center, Burlington
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-05 · NCT07005024Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- University of Vermont Medical Center, Burlington
- University of Vermount and Sate Agricultural College, Burlington
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2024-11-27 · NCT03860883Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.